Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mentha longifolia spray in patients with COVID-19
IRCT20200809048337N1Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jul 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of mentha longifolia in coronavirus disease 2019 (COVID-19), sponsored by Mazandaran University of Medical Sciences. Started Jul 2020; status: completed.
02
Drugs
mentha longifolia
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200809048337N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200809048337N1.